2024-04-012025-03-312025-03-31false05234769SHOREHAM ORAL CARE LTD2025-11-2986230falseiso4217:GBPxbrli:pure052347692024-03-31052347692025-03-31052347692024-04-012025-03-31052347692023-03-31052347692024-03-31052347692023-04-012024-03-3105234769bus:SmallEntities2024-04-012025-03-3105234769bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3105234769bus:FullAccounts2024-04-012025-03-3105234769bus:PrivateLimitedCompanyLtd2024-04-012025-03-3105234769core:WithinOneYear2025-03-3105234769core:AfterOneYear2025-03-3105234769core:WithinOneYear2024-03-3105234769core:AfterOneYear2024-03-3105234769core:ShareCapital2025-03-3105234769core:SharePremium2025-03-3105234769core:RevaluationReserve2025-03-3105234769core:OtherReservesSubtotal2025-03-3105234769core:RetainedEarningsAccumulatedLosses2025-03-3105234769core:ShareCapital2024-03-3105234769core:SharePremium2024-03-3105234769core:RevaluationReserve2024-03-3105234769core:OtherReservesSubtotal2024-03-3105234769core:RetainedEarningsAccumulatedLosses2024-03-3105234769core:LandBuildings2025-03-3105234769core:PlantMachinery2025-03-3105234769core:Vehicles2025-03-3105234769core:FurnitureFittings2025-03-3105234769core:OfficeEquipment2025-03-3105234769core:NetGoodwill2025-03-3105234769core:IntangibleAssetsOtherThanGoodwill2025-03-3105234769core:ListedExchangeTraded2025-03-3105234769core:UnlistedNon-exchangeTraded2025-03-3105234769core:LandBuildings2024-03-3105234769core:PlantMachinery2024-03-3105234769core:Vehicles2024-03-3105234769core:FurnitureFittings2024-03-3105234769core:OfficeEquipment2024-03-3105234769core:NetGoodwill2024-03-3105234769core:IntangibleAssetsOtherThanGoodwill2024-03-3105234769core:ListedExchangeTraded2024-03-3105234769core:UnlistedNon-exchangeTraded2024-03-3105234769core:LandBuildings2024-04-012025-03-3105234769core:PlantMachinery2024-04-012025-03-3105234769core:Vehicles2024-04-012025-03-3105234769core:FurnitureFittings2024-04-012025-03-3105234769core:OfficeEquipment2024-04-012025-03-3105234769core:NetGoodwill2024-04-012025-03-3105234769core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3105234769core:ListedExchangeTraded2024-04-012025-03-3105234769core:UnlistedNon-exchangeTraded2024-04-012025-03-3105234769core:MoreThanFiveYears2024-04-012025-03-3105234769core:Non-currentFinancialInstruments2025-03-3105234769core:Non-currentFinancialInstruments2024-03-3105234769dpl:CostSales2024-04-012025-03-3105234769dpl:DistributionCosts2024-04-012025-03-3105234769core:LandBuildings2024-04-012025-03-3105234769core:PlantMachinery2024-04-012025-03-3105234769core:Vehicles2024-04-012025-03-3105234769core:FurnitureFittings2024-04-012025-03-3105234769core:OfficeEquipment2024-04-012025-03-3105234769dpl:AdministrativeExpenses2024-04-012025-03-3105234769core:NetGoodwill2024-04-012025-03-3105234769core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3105234769dpl:GroupUndertakings2024-04-012025-03-3105234769dpl:ParticipatingInterests2024-04-012025-03-3105234769dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3105234769core:ListedExchangeTraded2024-04-012025-03-3105234769dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3105234769core:UnlistedNon-exchangeTraded2024-04-012025-03-3105234769dpl:CostSales2023-04-012024-03-3105234769dpl:DistributionCosts2023-04-012024-03-3105234769core:LandBuildings2023-04-012024-03-3105234769core:PlantMachinery2023-04-012024-03-3105234769core:Vehicles2023-04-012024-03-3105234769core:FurnitureFittings2023-04-012024-03-3105234769core:OfficeEquipment2023-04-012024-03-3105234769dpl:AdministrativeExpenses2023-04-012024-03-3105234769core:NetGoodwill2023-04-012024-03-3105234769core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3105234769dpl:GroupUndertakings2023-04-012024-03-3105234769dpl:ParticipatingInterests2023-04-012024-03-3105234769dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3105234769core:ListedExchangeTraded2023-04-012024-03-3105234769dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3105234769core:UnlistedNon-exchangeTraded2023-04-012024-03-3105234769core:NetGoodwill2025-03-3105234769core:IntangibleAssetsOtherThanGoodwill2025-03-3105234769core:LandBuildings2025-03-3105234769core:PlantMachinery2025-03-3105234769core:Vehicles2025-03-3105234769core:FurnitureFittings2025-03-3105234769core:OfficeEquipment2025-03-3105234769core:AfterOneYear2025-03-3105234769core:WithinOneYear2025-03-3105234769core:ListedExchangeTraded2025-03-3105234769core:UnlistedNon-exchangeTraded2025-03-3105234769core:ShareCapital2025-03-3105234769core:SharePremium2025-03-3105234769core:RevaluationReserve2025-03-3105234769core:OtherReservesSubtotal2025-03-3105234769core:RetainedEarningsAccumulatedLosses2025-03-3105234769core:NetGoodwill2024-03-3105234769core:IntangibleAssetsOtherThanGoodwill2024-03-3105234769core:LandBuildings2024-03-3105234769core:PlantMachinery2024-03-3105234769core:Vehicles2024-03-3105234769core:FurnitureFittings2024-03-3105234769core:OfficeEquipment2024-03-3105234769core:AfterOneYear2024-03-3105234769core:WithinOneYear2024-03-3105234769core:ListedExchangeTraded2024-03-3105234769core:UnlistedNon-exchangeTraded2024-03-3105234769core:ShareCapital2024-03-3105234769core:SharePremium2024-03-3105234769core:RevaluationReserve2024-03-3105234769core:OtherReservesSubtotal2024-03-3105234769core:RetainedEarningsAccumulatedLosses2024-03-3105234769core:NetGoodwill2023-03-3105234769core:IntangibleAssetsOtherThanGoodwill2023-03-3105234769core:LandBuildings2023-03-3105234769core:PlantMachinery2023-03-3105234769core:Vehicles2023-03-3105234769core:FurnitureFittings2023-03-3105234769core:OfficeEquipment2023-03-3105234769core:AfterOneYear2023-03-3105234769core:WithinOneYear2023-03-3105234769core:ListedExchangeTraded2023-03-3105234769core:UnlistedNon-exchangeTraded2023-03-3105234769core:ShareCapital2023-03-3105234769core:SharePremium2023-03-3105234769core:RevaluationReserve2023-03-3105234769core:OtherReservesSubtotal2023-03-3105234769core:RetainedEarningsAccumulatedLosses2023-03-3105234769core:AfterOneYear2024-04-012025-03-3105234769core:WithinOneYear2024-04-012025-03-3105234769core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3105234769core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3105234769core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3105234769core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3105234769core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3105234769core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3105234769core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3105234769core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3105234769core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3105234769core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3105234769core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3105234769core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3105234769core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3105234769core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3105234769core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3105234769core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3105234769core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3105234769core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3105234769core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3105234769core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3105234769core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3105234769core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3105234769core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3105234769core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3105234769core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3105234769core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3105234769core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3105234769bus:Director12024-04-012025-03-3105234769bus:Director22024-04-012025-03-3105234769bus:Director32024-04-012025-03-3105234769bus:Director42024-04-012025-03-3105234769core:FurnitureFittingsToolsEquipment2024-03-3105234769core:FurnitureFittingsToolsEquipment2024-04-012025-03-3105234769core:FurnitureFittingsToolsEquipment2025-03-31

SHOREHAM ORAL CARE LTD

Registered Number
05234769
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

SHOREHAM ORAL CARE LTD
Company Information
for the year from 1 April 2024 to 31 March 2025

Directors

Dr N Julka
Dr S Patel
Dr J Patel
Dr R K Sethi

Registered Address

2nd Floor Grove House
55 Lowlands Road
Harrow
HA1 3AW

Registered Number

05234769 (England and Wales)
SHOREHAM ORAL CARE LTD
Balance Sheet as at
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Intangible assets360,000120,000
Tangible assets4383,937392,115
443,937512,115
Current assets
Stocks53,5003,500
Debtors62,649,2982,660,652
Cash at bank and on hand161,92394,345
2,814,7212,758,497
Creditors amounts falling due within one year7(361,953)(235,372)
Net current assets (liabilities)2,452,7682,523,125
Total assets less current liabilities2,896,7053,035,240
Creditors amounts falling due after one year8(1,121,691)(1,195,135)
Provisions for liabilities9(9,937)(11,057)
Net assets1,765,0771,829,048
Capital and reserves
Called up share capital22
Profit and loss account1,765,0751,829,046
Shareholders' funds1,765,0771,829,048
The financial statements were approved and authorised for issue by the Board of Directors on 29 November 2025, and are signed on its behalf by:
Dr J Patel
Director
Dr N Julka
Director
Dr S Patel
Director

Registered Company No. 05234769
SHOREHAM ORAL CARE LTD
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Intangible assets
Goodwill represents the excess of the cost of acquisition of unincorporated business over the fair valuer of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortasation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on systematic basis over its expected life, which is 20 years.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)
Land and buildings1
Plant and machinery20
Fixtures and fittings30
Office Equipment30
Stocks and work in progress
Stocks are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).
Financial instruments
Financial instruments Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognized amounts and there is an intention to settle on a Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously. Basic financial assets Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised. Classification of financial liabilities Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Basic financial liabilities Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
2.Average number of employees

20252024
Average number of employees during the year1617
3.Intangible assets

Goodwill

Total

££
Cost or valuation
At 01 April 24600,000600,000
At 31 March 25600,000600,000
Amortisation and impairment
At 01 April 24480,000480,000
Charge for year60,00060,000
At 31 March 25540,000540,000
Net book value
At 31 March 2560,00060,000
At 31 March 24120,000120,000
4.Tangible fixed assets

Land & buildings

Plant & machinery

Fixtures & fittings

Office Equipment

Total

£££££
Cost or valuation
At 01 April 24383,233188,47915,2068,046594,964
Additions-778-5,2336,011
At 31 March 25383,233189,25715,20613,279600,975
Depreciation and impairment
At 01 April 2436,646153,5539,9102,740202,849
Charge for year3,4657,0881,5892,04714,189
At 31 March 2540,111160,64111,4994,787217,038
Net book value
At 31 March 25343,12228,6163,7078,492383,937
At 31 March 24346,58734,9265,2965,306392,115
5.Stocks

2025

2024

££
Other stocks3,5003,500
Total3,5003,500
6.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables39,91116,514
Amounts owed by group undertakings1,676,5821,676,582
Other debtors930,950965,450
Prepayments and accrued income1,8552,106
Total2,649,2982,660,652
7.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables23,72125,362
Bank borrowings and overdrafts107,415107,415
Taxation and social security-7,105
Other creditors227,81892,490
Accrued liabilities and deferred income2,9993,000
Total361,953235,372
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
8.Creditors: amounts due after one year

2025

2024

££
Bank borrowings and overdrafts1,121,6911,195,135
Total1,121,6911,195,135
9.Provisions for liabilities

2025

2024

££
Net deferred tax liability (asset)9,93711,057
Total9,93711,057
10.Related party transactions
Including in the amount owed by the group is £1,676,582 (2024 £1,676,582) owed by Teeth R Us Ltd related as part of group company. Other debtors includes following balances: Quality Dental Practices Ltd,: £30,950 (2024: £30,950) Crossway Dental Practice £635,000 Quality Dental Fulham Limited: £227,500. QD Wimbledon- £37,500 Other Creditors includes following balances: - QD Boulevard- £80,000 - Quality Dental Albion Limited- £80,000